ES2104572T3 - N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2104572T3
ES2104572T3 ES90118376T ES90118376T ES2104572T3 ES 2104572 T3 ES2104572 T3 ES 2104572T3 ES 90118376 T ES90118376 T ES 90118376T ES 90118376 T ES90118376 T ES 90118376T ES 2104572 T3 ES2104572 T3 ES 2104572T3
Authority
ES
Spain
Prior art keywords
physostigmine
medicines
procedure
preparation
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90118376T
Other languages
English (en)
Spanish (es)
Inventor
Edward Joseph Glamkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2104572T3 publication Critical patent/ES2104572T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ES90118376T 1989-09-28 1990-09-25 N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2104572T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/413,901 US4914102A (en) 1989-09-28 1989-09-28 N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US07/431,103 US5081117A (en) 1989-09-28 1989-11-03 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
ES2104572T3 true ES2104572T3 (es) 1997-10-16

Family

ID=40149690

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90118376T Expired - Lifetime ES2104572T3 (es) 1989-09-28 1990-09-25 N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
ES90121267T Expired - Lifetime ES2085309T3 (es) 1989-09-28 1990-11-07 4- y 6-carbamatos relacionados con fisostigmina, un procedimiento y productos intermedios para su preparacion y su uso como medicamentos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES90121267T Expired - Lifetime ES2085309T3 (es) 1989-09-28 1990-11-07 4- y 6-carbamatos relacionados con fisostigmina, un procedimiento y productos intermedios para su preparacion y su uso como medicamentos.

Country Status (21)

Country Link
US (2) US4914102A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP0420140B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPH0723377B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100189665B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (2) ATE156825T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (3) AU639943B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (2) CA2026381A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ279604B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE69031259T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK0420140T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2104572T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (2) FI93961C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (2) GR3019468T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU206355B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE72153B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL95807A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (2) NO174469B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (2) NZ235460A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL287618A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (2) PT95449B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (2) ZA907725B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
ATE125254T1 (de) * 1989-09-19 1995-08-15 Hoechst Roussel Pharma Verfahren zur racematspaltung von 5-alkoxy- substituierten (+/-)-1,3- dimethyloxindolylethylaminen.
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
SG52631A1 (en) * 1990-01-22 1998-09-28 Hoechst Roussel Pharma Process for the enantioselection sznthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine
DE69032046T2 (de) * 1990-06-27 1998-08-27 Hoechst Marion Roussel Inc Tetrahydroisochinolinylcarbamate von 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo [2,3-b] indol
EP0606366B1 (en) * 1991-09-26 2003-06-04 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
US5171750A (en) * 1991-09-26 1992-12-15 The United States Of America As Represented By The Department Of Health And Human Services Substituted phenserines as specific inhibitors of acetylcholinesterase
US5153193A (en) * 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
IT1253007B (it) * 1991-12-31 1995-07-10 Aesculapius Farma Srl Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FI933264A7 (fi) * 1992-07-21 1994-01-22 Hoechst Roussel Pharma Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
US5302721A (en) * 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
DK2389937T3 (en) * 2002-06-14 2018-11-12 Toyama Chemical Co Ltd Medical composition to improve brain function
AU2004285893B2 (en) * 2003-10-21 2011-12-15 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
WO2005072713A2 (en) 2004-01-27 2005-08-11 The Feinstein Institute For Medical Research Cholinesterase inhibitors for treating inflammation
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
WO2005123068A2 (en) * 2004-06-08 2005-12-29 Axonyx, Inc. Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor
WO2006060082A1 (en) * 2004-10-22 2006-06-08 THE GOVERNMENT OF THE U.S.A. as represented by THE SEC., DEPT. OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH Tricyclic compounds, preparation thereof and use thereof as cholinesterase activity inhibitors
EA202092673A3 (ru) * 2010-02-09 2021-05-31 Дзе Джонс Хопкинс Юниверсити Способы и композиции для улучшения когнитивной функции
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
RU2635528C2 (ru) 2012-12-13 2017-11-13 Х. Лундбекк А/С Композиции, содержащие вортиоксетин и донепезил
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897451A (en) * 1973-04-27 1975-07-29 Univ Ohio State Res Found Synthesis of oxindoles from anilines and intermediates therein
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US4741107A (en) * 1987-07-31 1988-05-03 Circle Jeffrey L Artwork aid adapted for facilitating placement of lettering along arc of a circle
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
ATE125254T1 (de) * 1989-09-19 1995-08-15 Hoechst Roussel Pharma Verfahren zur racematspaltung von 5-alkoxy- substituierten (+/-)-1,3- dimethyloxindolylethylaminen.
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
SG52631A1 (en) * 1990-01-22 1998-09-28 Hoechst Roussel Pharma Process for the enantioselection sznthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine

Also Published As

Publication number Publication date
PT95449B (pt) 1997-07-31
NO175980C (no) 1995-01-11
NO175980B (no) 1994-10-03
IL96209A (en) 1995-07-31
PT95449A (pt) 1991-05-22
US5081117A (en) 1992-01-14
ES2085309T3 (es) 1996-06-01
FI93961B (fi) 1995-03-15
PL287618A1 (en) 1992-05-04
GR3025021T3 (en) 1998-01-30
FI904730A0 (fi) 1990-09-26
ZA907725B (en) 1991-07-31
NO904209D0 (no) 1990-09-27
DE69025941T2 (de) 1996-09-05
AU6322790A (en) 1991-04-11
FI92701C (fi) 1994-12-27
FI93961C (fi) 1995-06-26
GR3019468T3 (en) 1996-06-30
HU906999D0 (en) 1991-05-28
DE69031259T2 (de) 1998-01-15
DK0420140T3 (da) 1998-03-16
CA2026381A1 (en) 1991-03-29
IE72153B1 (en) 1997-03-26
ATE135355T1 (de) 1996-03-15
IE903965A1 (en) 1991-05-08
IL96209A0 (en) 1991-08-16
JPH0780885B2 (ja) 1995-08-30
AU639943B2 (en) 1993-08-12
EP0484573B1 (en) 1996-03-13
EP0420140B1 (en) 1997-08-13
NO904783L (no) 1991-05-06
PT95772A (pt) 1991-09-13
EP0420140A2 (en) 1991-04-03
HUT57772A (en) 1991-12-30
DE69031259D1 (de) 1997-09-18
DK0484573T3 (da) 1996-07-22
NO174469B (no) 1994-01-31
US4914102A (en) 1990-04-03
CA2029265A1 (en) 1991-05-04
PT95772B (pt) 1997-11-28
JPH03153688A (ja) 1991-07-01
NO904209L (no) 1991-04-02
IL95807A0 (en) 1991-06-30
CZ279604B6 (cs) 1995-05-17
DE69025941D1 (de) 1996-04-18
NO174469C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-05-18
AU635575B2 (en) 1993-03-25
FI92701B (fi) 1994-09-15
NO904783D0 (no) 1990-11-02
AU6571290A (en) 1991-05-23
ZA908800B (en) 1991-08-28
IL95807A (en) 1994-10-21
HU206355B (en) 1992-10-28
FI905418A0 (fi) 1990-11-01
KR100189665B1 (ko) 1999-06-01
JPH03120281A (ja) 1991-05-22
AU3204693A (en) 1993-03-25
JPH0723377B2 (ja) 1995-03-15
NZ235921A (en) 1994-10-26
EP0420140A3 (en) 1991-11-13
EP0484573A1 (en) 1992-05-13
NZ235460A (en) 1993-01-27
KR910009706A (ko) 1991-06-28
CZ540790A3 (en) 1994-11-16
ATE156825T1 (de) 1997-08-15
AU646986B2 (en) 1994-03-10
CA2029265C (en) 2001-08-14

Similar Documents

Publication Publication Date Title
ES2104572T3 (es) N-aminocarbamatos afines a la fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
TR200100917T2 (tr) Aril ve heteroaril sübstitüentli heteroksiklik üreler kullanılarak RAF kinazın inhibe edilmesi
ES2083464T3 (es) Compuestos heterociclicos.
ES2057197T3 (es) Derivados de quinolina y procedimiento para su preparacion.
MX173140B (es) Derivados aromaticos y heterociclicos de carboxamida, utiles como agentes antitumorales y procedimiento para su preparacion
AR022303A1 (es) Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
ES2096643T3 (es) Piridilsulfonilureas como herbicidas y reguladoras del crecimiento de las plantas, procedimientos para su preparacion y su utilizacion.
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
ES2052598T3 (es) Derivados de hetaril-oxi-beta-carbolinas, su preparacion y utilizacion como medicamentos.
ES2086579T3 (es) Antagonista de leucotrieno b4.
AR013152A1 (es) Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n.
ES2157201T3 (es) Derivados carbamato de 4-amino-3-isoxazolidinonas y 3-amino-1-hidroxipirrolidin-2-onas, un procedimiento para su preparacion y su uso como medicamentos.
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
ES2059677T3 (es) 1,2,3,4-tetrahidro-1,9-acridindiaminas, un procedimiento para su preparacion y su uso como medicamentos.
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
MX9206816A (es) Derivados de cromano substituidos con piperidilmetilo, procedimiento para su obtencion y medicamentoque los contiene.
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them
DE3781483D1 (de) Pharmazeutische zusammensetzung zum schutz von gehirnzellen.
SE8602523L (sv) 2-alkyl- eller -aralkyltio-1-cykloalken-1-karboxamider och deras sulfoxider, sett for deras framstellning och deras anvendning for syntes av tri- och 4,5-tetrametylen-4-isotiazolin-3-oner
ES2077042T3 (es) Derivados de benzoxazina, derivados de benzotiazina y herbicidas que comprenden los mismos.
ES2053536T3 (es) Compuestos heterociclicos.
AR029148A1 (es) Compuestos derivados de ureido piperidina, procedimiento para su obtencion, compuestos intermediarios, composiciones farmaceuticas que los contienen, y el uso de los mismos para la preparacion de medicamentos
DE68924545D1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 420140

Country of ref document: ES